| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.00098 | 1 |